{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:44:35Z","timestamp":1794023075904,"version":"4.8.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jchf.2026.103046","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:28:01Z","timestamp":1774826881000},"page":"103046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Excess and Dysfunctional Fat as a Primary Driver of Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"14","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-4768","authenticated-orcid":false,"given":"Jennifer","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-7171","authenticated-orcid":false,"given":"Gabriele G.","family":"Schiattarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2026.103046_bib1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC Expert Consensus Decision Pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.jchf.2026.103046_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102714","article-title":"Rationale and design of the HeartShare\/AMP-HF deep phenotyping study to improve understanding of heart failure with preserved ejection fraction","volume":"13","author":"Borlaug","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.jchf.2026.103046_bib4","article-title":"Characterizing heart failure across the spectrum of the preserved ejection fraction: does heart failure with supranormal ejection fraction exist? Data from the Swedish Heart Failure Registry","volume":"14","author":"Landucci","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103046_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(84)80207-6","article-title":"Congestive heart failure with normal systolic function","volume":"54","author":"Dougherty","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1532-5415.1982.tb01983.x","article-title":"Left ventricular function in hospitalized geriatric patients","volume":"30","author":"Luchi","year":"1982","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jchf.2026.103046_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","article-title":"Hypertensive hypertrophic cardiomyopathy of the elderly","volume":"312","author":"Topol","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib8","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","article-title":"Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms","volume":"11","author":"Maurer","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000053947.82595.03","article-title":"Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?","volume":"107","author":"Burkhoff","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cardfail.2011.03.010","article-title":"The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction","volume":"17","author":"Abramov","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib13","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103046_bib15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103046_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103046_bib17","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1038\/s41591-025-03939-6","article-title":"Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103046_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib19","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2025.09.1503","article-title":"Trends in the prevalence, associated risk factors, and health burden of heart failure in the United States, 1988 to 2023","volume":"86","author":"Sayed","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCHEARTFAILURE.112.968594","article-title":"Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study","volume":"5","author":"Mohammed","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib21","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2025.03.530","article-title":"Disentangling the impact of adiposity from insulin resistance in heart failure with preserved ejection fraction","volume":"85","author":"Reddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","article-title":"Relationship between physical activity, body mass index, and risk of heart failure","volume":"69","author":"Pandey","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib25","first-page":"100688","article-title":"Obesity burden among heart failure patients in an urban safety net hospital: implications for GLP-1 agonist therapy","volume":"61","author":"Yee","year":"2025","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.jchf.2026.103046_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jchf.2026.103046_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ejhf.3092","article-title":"Obesity in heart failure with preserved ejection fraction: insights from the REDUCE LAP-HF II trial","volume":"26","author":"Litwin","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.mayocp.2023.07.008","article-title":"Obesity, cardiorenal comorbidities, and risk of hospitalization in patients with heart failure with preserved ejection fraction","volume":"98","author":"Morgen","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.jchf.2026.103046_bib30","article-title":"Myocardial proteome in human heart failure with preserved ejection fraction","volume":"14","author":"Jani","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103046_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s44161-024-00516-x","article-title":"Myocardial ultrastructure of human heart failure with preserved ejection fraction","volume":"3","author":"Meddeb","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.103046_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.120.052414","article-title":"Reduced right ventricular sarcomere contractility in heart failure with preserved ejection fraction and severe obesity","volume":"143","author":"Aslam","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","article-title":"Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods","volume":"13","author":"Obokata","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12933-025-02738-0","article-title":"Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12937-024-01048-7","article-title":"Neck circumference, waist-to-height ratio, Chinese visceral adiposity index and incident heart failure","volume":"23","author":"Wu","year":"2024","journal-title":"Nutr J"},{"key":"10.1016\/j.jchf.2026.103046_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/2047487319851298","article-title":"Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction","volume":"26","author":"Campbell","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103046_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002711","article-title":"Adiposity, fat-free mass and incident heart failure in 500 000 individuals","volume":"11","author":"Oguntade","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2026.103046_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib40","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103046_bib41","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2025.08.012","article-title":"Adiposity-related anthropometrics and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: a participant-level pooled analysis of randomized clinical trials","volume":"86","author":"Ostrominski","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jchf.2026.103046_bib42","doi-asserted-by":"crossref","first-page":"e014031","DOI":"10.1161\/CIRCHEARTFAILURE.125.014031","article-title":"What exactly is \u201ccardiometabolic HFpEF\u201d: a phenotype or an endotype?","volume":"19","author":"Packer","year":"2026","journal-title":"Circ Heart Fail"},{"issue":"22","key":"10.1016\/j.jchf.2026.103046_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.000223","article-title":"Sex differences in protein biomarkers and measures of fat distribution","volume":"13","author":"Ramirez","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103046_bib44","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103046_bib45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jchf.2026.103046_bib46","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103046_bib47","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2025.07.052","article-title":"Is type 2 diabetes a modifiable risk factor for the evolution and progression of heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103046_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/biom15020213","article-title":"From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jchf.2026.103046_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2026.103046_bib50","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2025.08.100","article-title":"The basics of metabolic dysfunction-associated steatotic liver disease for cardiologists: pathophysiology, diagnosis, and treatment","volume":"86","author":"Khan","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib51","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.125.325602","article-title":"Cardiovascular, kidney, liver, and metabolic interactions in heart failure: breaking down silos","volume":"136","author":"Lee","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103046_bib52","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.122.320257","article-title":"Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models","volume":"130","author":"Roh","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103046_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/FJC.0b013e3182102c3b","article-title":"Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats","volume":"57","author":"Chan","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl N","key":"10.1016\/j.jchf.2026.103046_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/16.suppl_N.19","article-title":"The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure","volume":"16","author":"Boluyt","year":"1995","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jchf.2026.103046_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015009","article-title":"Phenotyping heart failure according to the longitudinal ejection fraction change: myocardial strain, predictors, and outcomes","volume":"9","author":"Park","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jchf.2026.103046_bib56","article-title":"What is cardiometabolic HFpEF and how can we study it preclinically?","volume":"10","author":"Daou","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103046_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JME-18-0242","article-title":"Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice","volume":"63","author":"Xu","year":"2019","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.jchf.2026.103046_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210252","article-title":"PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice","volume":"218","author":"Cheng","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jchf.2026.103046_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41598-024-84515-9","article-title":"Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension","volume":"15","author":"Berger","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchf.2026.103046_bib61","doi-asserted-by":"crossref","first-page":"H51","DOI":"10.1152\/ajpheart.00092.2025","article-title":"Relative contribution of correcting the diet and voluntary exercise to myocardial recovery in a two-hit murine model of heart failure with preserved ejection fraction","volume":"329","author":"Labb\u00e9","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103046_bib62","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib64","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib65","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2025.08.036","article-title":"Central adiposity or hypertension: which drives heart failure with a preserved ejection fraction?","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib66","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jacc.2025.08.086","article-title":"Chronic kidney disease in patients with heart failure with a preserved ejection fraction: the underlying role of visceral adiposity","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib67","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib68","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib69","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib70","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103046_bib71","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","article-title":"Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis","volume":"22","author":"Myasoedova","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.jchf.2026.103046_bib73","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/cells11081264","article-title":"The effect of mineralocorticoid receptor antagonists on anti-inflammatory and anti-fatty acid transport profile in patients with heart failure","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jchf.2026.103046_bib74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2019.04.039","article-title":"Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk?","volume":"292","author":"Dozio","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacbts.2023.05.007","article-title":"Empagliflozin suppresses the differentiation\/maturation of human epicardial preadipocytes and improves paracrine secretome profile","volume":"8","author":"Takano","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103046_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2010-0674","article-title":"Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome","volume":"152","author":"Caprio","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.jchf.2026.103046_bib77","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db15-1627","article-title":"Adipocyte-specific mineralocorticoid receptor overexpression in mice is associated with metabolic syndrome and vascular dysfunction: role of redox-sensitive PKG-1 and Rho kinase","volume":"65","author":"Nguyen Dinh Cat","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jchf.2026.103046_bib78","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/ehf2.15396","article-title":"Epicardial, visceral and subcutaneous adipose tissue in heart failure with preserved ejection fraction","volume":"12","author":"Lobeek","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12872-021-02080-9","article-title":"Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2026.103046_bib80","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabres.2018.08.005","article-title":"Anthropometric indices as surrogates for estimating abdominal visceral and subcutaneous adipose tissue: a meta-analysis with 16,129 participants","volume":"143","author":"Ping","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jchf.2026.103046_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjcard.2014.10.039","article-title":"Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study)","volume":"115","author":"Nazare","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib82","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/oby.2007.92","article-title":"Visceral fat, waist circumference, and BMI: impact of race\/ethnicity","volume":"16","author":"Carroll","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"23","key":"10.1016\/j.jchf.2026.103046_bib83","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.3390\/ijerph192315521","article-title":"The sex and race\/ethnicity-specific relationships of abdominal fat distribution and anthropometric indices in US adults","volume":"19","author":"Xu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib84","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a Scientific Statement from the American Heart Association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib85","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.arr.2009.06.001","article-title":"Age-related changes in total and regional fat distribution","volume":"8","author":"Kuk","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jchf.2026.103046_bib86","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3945\/ajcn.2008.27358","article-title":"The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"90","author":"Ding","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jchf.2026.103046_bib87","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12933-024-02474-x","article-title":"Epicardial fat density obtained with computed tomography imaging\u2014more important than volume?","volume":"23","author":"Nogajski","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103046_bib89","doi-asserted-by":"crossref","first-page":"101947","DOI":"10.1016\/j.jocmr.2025.101947","article-title":"Preclinical magnetic resonance imaging of proinflammatory epicardial adipose tissue: accelerated methods for simultaneous fatty acid composition and relaxation parameter mapping with relationships to tissue biomarkers","volume":"27","author":"Bresticker","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jchf.2026.103046_bib90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13139-022-00785-z","article-title":"The presence of residual vascular and adipose tissue inflammation on (18)F-FDG PET in patients with chronic coronary artery disease","volume":"57","author":"Toivonen","year":"2023","journal-title":"Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.jchf.2026.103046_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006939","article-title":"Elevated angiotensin 1-7\/angiotensin II ratio predicts favorable outcomes in patients With heart failure","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"510","key":"10.1016\/j.jchf.2026.103046_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5055","article-title":"Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17\/RAC1-mediated activation of NADPH oxidases","volume":"11","author":"Akoumianakis","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jchf.2026.103046_bib93","doi-asserted-by":"crossref","first-page":"420","DOI":"10.33963\/KP.15257","article-title":"Relationship among the leptin-to-adiponectin ratio, systemic inflammation, and anisocytosis in well-controlled type 2 diabetic patients with atherosclerotic cardiovascular disease","volume":"78","author":"Rostoff","year":"2020","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jchf.2026.103046_bib94","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2015.05.007","article-title":"Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome","volume":"104","author":"Sarray","year":"2015","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.jchf.2026.103046_bib95","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015343","article-title":"Characterization, pathogenesis, and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation","volume":"9","author":"Packer","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103046_bib96","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.124.068788","article-title":"Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction: insights from the CAMEO-DAPA trial","volume":"150","author":"Tada","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103046_bib97","doi-asserted-by":"crossref","first-page":"117490","DOI":"10.1016\/j.atherosclerosis.2024.117490","article-title":"Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: a network meta-analysis","volume":"391","author":"Kim","year":"2024","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jchf.2026.103046_bib98","doi-asserted-by":"crossref","first-page":"e14256","DOI":"10.1111\/eci.14256","article-title":"Role of endogenous GLP-1 on arterial stiffness and renal haemodynamics following bariatric surgery","volume":"54","author":"Moriconi","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-025-02985-1","article-title":"Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation","volume":"25","author":"Meulendijks","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jchf.2026.103046_bib100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib101","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib102","doi-asserted-by":"crossref","first-page":"156463","DOI":"10.1016\/j.metabol.2025.156463","article-title":"Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: systematic review and meta-analysis of randomized controlled trials","volume":"175","author":"Karakasis","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.jchf.2026.103046_bib103","doi-asserted-by":"crossref","first-page":"1558367","DOI":"10.3389\/fphar.2025.1558367","article-title":"Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jchf.2026.103046_bib104","first-page":"103","article-title":"Age related shift in visceral fat","volume":"8","author":"Hunter","year":"2010","journal-title":"Int J Body Compos Res"},{"key":"10.1016\/j.jchf.2026.103046_bib105","article-title":"Inflammation and cardiovascular diseases in the elderly: the role of epicardial adipose tissue","volume":"9","author":"Conte","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jchf.2026.103046_bib106","doi-asserted-by":"crossref","first-page":"e12950","DOI":"10.1111\/acel.12950","article-title":"Targeting senescent cells alleviates obesity-induced metabolic dysfunction","volume":"18","author":"Palmer","year":"2019","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib107","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000720","article-title":"Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy","volume":"7","author":"Bian","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jchf.2026.103046_bib108","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/cvr\/cvab234","article-title":"Resistin deletion protects against heart failure injury by targeting DNA damage response","volume":"118","author":"Zhao","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.103046_bib109","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1253\/circj.CJ-12-0350","article-title":"Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement","volume":"76","author":"Chavarria","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2026.103046_bib110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCHEARTFAILURE.111.964031","article-title":"Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation","volume":"5","author":"Khan","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib111","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2025.08.055","article-title":"Adipokine-cardiomyocyte crosstalk: a 2-way street in HFpEF pathogenesis?","volume":"86","author":"Frey","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jchf.2026.103046_bib112","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"V\u00e9niant","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.jchf.2026.103046_bib113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.01.040","article-title":"Human GIP(3-30)NH(2) inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors","volume":"150","author":"Gabe","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jchf.2026.103046_bib114","doi-asserted-by":"crossref","first-page":"648212","DOI":"10.3389\/fcvm.2021.648212","article-title":"The association between metformin treatment and outcomes in type 2 diabetes mellitus patients with heart failure with preserved ejection fraction: a retrospective study","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-020-01100-w","article-title":"Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis","volume":"19","author":"Halabi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jchf.2026.103046_bib116","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2019.11.087","article-title":"Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension","volume":"306","author":"Gu","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.103046_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1085\/jgp.201812259","article-title":"Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance","volume":"151","author":"Slater","year":"2019","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jchf.2026.103046_bib118","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jchf.2026.103046_bib119","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41467-025-56885-9","article-title":"FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jchf.2026.103046_bib120","doi-asserted-by":"crossref","first-page":"1064290","DOI":"10.3389\/fcvm.2023.1064290","article-title":"Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure","volume":"10","author":"Joshi","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jchf.2026.103046_bib121","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jchf.2026.103046_bib122","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010618","article-title":"Obesity-related biomarkers are associated with exercise intolerance and HFpEF","volume":"16","author":"Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib123","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/ehf2.14959","article-title":"IL-6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction","volume":"11","author":"Berger","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103046_bib124","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/JIR.S459989","article-title":"Prognostic value of inflammatory cytokines in predicting hospital readmissions in heart failure with preserved ejection fraction","volume":"17","author":"Zhao","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jchf.2026.103046_bib125","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jchf.2023.06.031","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10.1016\/j.jchf.2026.103046_bib126","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018549","article-title":"Interleukin 6 and development of heart failure with preserved ejection fraction in the general population","volume":"10","author":"Chia","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103046_bib127","article-title":"Inflamed adipose tissue: a culprit underlying obesity and heart failure with preserved ejection fraction","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:44:14Z","timestamp":1792093454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":127,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213177926001459"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103046","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excess and Dysfunctional Fat as a Primary Driver of Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103046"}}